Company Filing History:
Years Active: 2003
Title: Ian Gordon Armitage: Innovator in Retroviral Treatment
Introduction
Ian Gordon Armitage is a notable inventor based in Arlesey, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diseases caused by retroviruses. His innovative work has led to the development of a unique compound that holds promise for medical applications.
Latest Patents
Armitage holds a patent for a compound titled "Calcium (3S) tetrahydro-3-furanyl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-(phosphonooxy)propylcarbamate." This invention relates to the compound itself, processes for its preparation, and its potential use in treating retroviral diseases. The patent showcases his expertise in medicinal chemistry and his commitment to advancing healthcare solutions.
Career Highlights
Ian Gordon Armitage is associated with SmithKline Beecham Corporation, where he has contributed to various research initiatives. His work at the company has allowed him to collaborate with other talented professionals in the field, enhancing the impact of his inventions.
Collaborations
Some of his notable coworkers include Andrew David Searle and Hardev Singh. Their collaborative efforts have likely played a role in the successful development of innovative solutions in the pharmaceutical industry.
Conclusion
Ian Gordon Armitage's contributions to the field of retroviral treatment through his patented invention highlight his role as a significant innovator. His work continues to inspire advancements in medical research and pharmaceutical development.